Last updated on November 2019

A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

Brief description of study

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 1291583 in healthy male and female subjects following oral administration of multiple rising doses over 4 weeks.

Clinical Study Identifier: NCT03868540

Find a site near you

Start Over